Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials

Journal of Hepatology

Volumn 13, Issue 2, 1991, Pages 192-199

  Tine', Fabio ^a   Magrin, Silvio ^a   Craxi', Antonio ^a   Pagliaro, Luigi ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS NON A NON B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; HEPATITIS, VIRAL, HUMAN; HUMAN; INTERFERON TYPE I, RECOMBINANT; META-ANALYSIS;

EID: 0025915674     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(91)90814-R     Document Type: Article

References (41)

1. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective
2. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
3. Hepatitis C virus antibodies among risk groups in Spain
4. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha Interferon: a preliminary report
5. An assay for circulating antiatitis
6. Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis
7. Meta-analysis of randomized clinical trials
8. Meta-analysis in clinical trials
9. Statistical aspects of the analysis of data from retrospective studies of disease
10. Meta-analysis in clinical research
11. Long-term treatment with low doses of interferon alfa-2b (rIFNa2b) in patients with chronic non-A, non-B (NANB) hepatitis: data of a multicenter randomized prospectively controlled trial
12. Effectiveness of long term lymphoblastoid interferon (L-IFN) treatment in chronic hepatitis C (CHC)
13. Randomized trial of lymphoblastoid alpha interferon in chronic non-A non-B hepatitis effects on inflammation and fibrogenesis
14. Recombinant alpha-interferon for chronic non-A, non-B hepatitis: optimal dose and factors associated with favourable response
15. Recombinant alphainterferon for chronic NANB hepatitis: optimal dose and factors associated with favourable response
16. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized controlled trial
17. Treatment of chronic NANB (type C) hepatitis with recombinant interferon alfa-2b Preliminary clinical results
18. Recombinant interferon alfa therapy for chronic hepatitis C A randomized double blind placebo-controlled trial
19. Recombinant interferon alpha 2b in the treatment of chronic non-A, non-B (NANB) hepatitis
20. Prolonged treat-terferon in comparison with a control group
21. One year therapy of non-A non-B/C chronic hepatitis with recombinant alpha-2a interferon (r-IFN) or lymphoblastoid alpha interferon (l-IFN)
22. A prospective randomized controlled trial of recombinant alpha interferon versus no treatment in non-A, non-B chronic active hepatitis (CAH): preliminary results
23. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A, non-B hepatitis
24. A controlled study of lymphoblastoid interferon in chronic non-A, non-B hepatitis
25. Randomized controlled trial of interferon α2b for chronic active hepatitis non-A, non-B: biochemical and histological evidence of remission
26. Better efficacy of high dose versus low dose recombinant interferon alpha-2b treatment in chronic non-A, non-B hepatitis
27. Randomized controlled trial of recombinant human alpha-interferon in patients with NANB chronic active hepatitis. Long-term response better with high than with low dose
28. Preliminary results of a randomized controlled trial with human lymphoblastoid interferon in chronic non-A, non-B hepatitis
29. Multicenter study on the treatment of chronic NANB hepatitis with recombinant human interferon alfa-2b
30. Recombinant human interferon alpha-2a in community-acquired non-A, non-B chronic hepatitis. Preliminary results of a randomized, controled trial
31. The management of community acquired NANB chronic hepatitis with interferon alfa-2a
32. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis
33. A randomized controlled open study of interferon alpha-2b treatment of chronic come to presence of hepatitis C virus antibodies
34. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience
35. Randomized controlled trial of recombinant alpha-2A interferon in chronic NANB posttransfusion hepatitis
36. Detection of hepatitis C viral sequences in non-A, non-B hepatitis
37. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen
38. Recombinant leukocyte interferon treatment of chronic hepatitis B
39. Quantitative methods in the review of epidemiologic literature
40. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective randomised trial